microRNA-32-5p
rnamiR-32-5p impairs endothelial KLF2 expression, compromising endothelial mechanotransduction and promoting erosion-type MI.
Pathway placement
Cascade stepEndothelial activation & erosion
Confidencemedium
RationaleDiagnostic biomarker for AMI; targets KLF2, a regulator of endothelial cell viability and mechanotransduction.
Also acts inVascular inflammation
Druggability
Not assessed (no mapped human gene target).
Assay & specimen
Class-level default (no specific cleared assay)— generic method inferred from analyte class; confirm against a specific product insert before use.
Specimen
Whole blood or cell-free plasma
Collection tube
PAXgene/Tempus RNA tube · K2/K3-EDTA (lavender-top)
Method / principle
RT-qPCR (TaqMan) or small-RNA sequencing
Reagent / substrate
Target-specific primers/probe; reverse transcriptase (miRNA: stem-loop RT primer)
Platform
qPCR instrument / NGS
Turnaround · availability
Research / send-out · Research (few LDTs)
Literature evidence(1)
- Silence of miR-32-5p promotes endothelial cell viability by targeting KLF2 and serves as a diagnostic biomarker of acute myocardial infarction.Diagnostic pathology · 2020 · PMID 32127011 · doi